ArticleNature communications2025

Personalized CRISPR knock-in cytokine gene therapy to remodel the tumor microenvironment and enhance CAR T cell therapy in solid tumors.

Michael Launspach et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.